Risk of incident renal cell carcinoma in patients with type 2 diabetes on sodium-glucose co-transporter-2 inhibitor users: a population-based cohort study

被引：0
|
作者：
Jong, G. P. [1 ]
Yang, T. Y. [2 ]
机构：
[1] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Taichung, Taiwan
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cardiovascular protection with sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Does it apply to all patients?
    Giorgino, Francesco
    Vora, Jiten
    Fenici, Peter
    Solini, Anna
    DIABETES OBESITY & METABOLISM, 2020, 22 (09): : 1481 - 1495
  • [42] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Dementia in People with Type 2 Diabetes-A Population-Based Cohort Study
    Tang, Huilin
    Shaaban, C. Elizabeth
    Wu, Yonghui
    Magoc, Tanja
    Donahoo, William T.
    Dekosky, Steven T.
    Bian, Jiang
    Guo, Jingchuan
    DIABETES, 2023, 72
  • [43] Effect of sodium-glucose co-transporter-2 inhibitors on coronary blood flow in patients with type 2 diabetes mellitus
    Tastan, E.
    Soner, S.
    Comert, A. D.
    Altunbas, M.
    Tuzun, R.
    Ozturk, C.
    Akyuz, A.
    Isik, F.
    Cap, M.
    Bilge, O.
    Suleymanoglu, M.
    Oksul, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (16) : 7620 - 7628
  • [44] Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium-glucose co-transporter-2 inhibitors in the USA: A retrospective cohort study
    Yuan, Zhong
    DeFalco, Frank J.
    Ryan, Patrick B.
    Schuemie, Martijn J.
    Stang, Paul E.
    Berlin, Jesse A.
    Desai, Mehul
    Rosenthal, Norm
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 582 - 589
  • [45] Sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients with type 2 diabetes mellitus: the road ahead
    Kramer, Caroline K.
    Zinman, Bernard
    EUROPEAN HEART JOURNAL, 2016, 37 (42) : 3201 - 3202
  • [46] Successful use of the sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with renal transplant and diabetes: a case series and literature review
    Gul, Wajiha
    Naem, Emad
    Elawad, Safa
    Elhadd, Tarik
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2021, 10 (04): : 222 - 224
  • [47] New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort study
    Cho, Yun Kyung
    Kim, Sehee
    Kim, Myung Jin
    Lee, Woo Je
    Kim, Ye-Jee
    Jung, Chang Hee
    DIABETES & METABOLISM, 2025, 51 (02)
  • [48] Sodium-glucose Cotransporter-2 Inhibitor Initiation, Risk of Recurrent Gout Flares, and Mortality in Patients with Gout and Type 2 Diabetes: A Population-based Cohort Study
    Wei, Jie
    Choi, Hyon K.
    Dalbeth, Nicola
    Li, Xiaoxiao
    Li, Changjun
    Zeng, Chao
    Lei, Guanghua
    Zhang, Yuqing
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 488 - 490
  • [49] Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study
    Jing-Xing Li
    Yu-Tung Hung
    Henry Bair
    Shu-Bai Hsu
    Chung-Yi Hsu
    Chun-Ju Lin
    Scientific Reports, 13 (1)
  • [50] Effect of sodium-glucose co-transporter-2 inhibitors on right ventricular function in patients with type 2 diabetes mellitus: A pilot study
    Patoulias, Dimitrios
    Toumpourleka, Maria
    Katsimardou, Alexandra
    Zografou, Ioanna
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Karagiannis, Asterios
    Doumas, Michael
    Papadopoulos, Christodoulos
    KARDIOLOGIA POLSKA, 2022, 80 (06) : 696 - 698
12345